Individual Shareholder Meeting

Published on September 23, 2014

Back to all press releases

On October 23, 2014 at Cellectis’ headquarters in Paris.

Event Details:

Date: October 23, 2014
Time: 6:00 to 8:30PM
Location: Cellectis – 11 rue Watt – 75013 Paris

André Choulika, PhD, Chairman and Chief Executive Officer of Cellectis, Mathieu Simon, MD, Executive Vice President and Thierry Moulin, Chief Financial Officer, will present to the Company's individual shareholders perspectives on developing immunotherapies based on engineering CART allogeneic (UCART) lymphocytes.
Feel free to send your questions ahead of the meeting at

Please RSVP with:

Cellectis / Jennifer Moore Phone: 01 81 69 16 00

Upon invitation – limited seats available

Download the PDF file